Tela Bio Inc (TELA)

$0.78 +0.03 (3.75%)
Market Cap 31.39M
Revenue (ttm) 69.30M
Net Income (ttm) -37.84M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -54.60%
Debt to Equity Ratio 26.60
Volume 254,800
Avg Vol 178,632
Day's Range N/A - N/A
Shares Out 40.34M
Stochastic %K 41%
Beta 0.88
Analysts Strong Sell
Price Target $3.45

Company Profile

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex...

Industry: Medical Devices
Sector: Healthcare
Phone: 484 320 2930
Address:
1 Great Valley Parkway, Suite 24, Malvern, United States
Dr_Monkeybreath
Dr_Monkeybreath Mar. 18 at 5:11 PM
$TELA make that 3,333 @ .7335.👍
0 · Reply
Dr_Monkeybreath
Dr_Monkeybreath Mar. 18 at 4:07 PM
$TELA 1,800 @ .747.🔒
0 · Reply
KylaGPS10x
KylaGPS10x Mar. 4 at 2:22 PM
$TELA over 70 percent institutional owned any hint of turn around with the new sales force and this rockets towards $3-$5
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Mar. 4 at 2:38 AM
$TELA RSI: 51.29, MACD: -0.0338 Vol: 0.04, MA20: 0.81, MA50: 0.96 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Bears2354
Bears2354 Mar. 2 at 3:46 PM
$TELA
0 · Reply
KylaGPS10x
KylaGPS10x Feb. 24 at 6:11 PM
$TELA company is a screaming buy u der a dollar. Once the new sales team gets to work the sales will increase 2-3 fold
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 23 at 12:10 PM
$TELA Current Stock Price: $0.72 Contracts to trade: $2.5 TELA Mar 20 2026 Call Entry: $0.05 Exit: $0.06 ROI: 31% Hold ~30 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Bears2354
Bears2354 Feb. 19 at 9:17 PM
$TELA nice bullish 1 month pendent. Should take off soon. And he out of this sub $1
0 · Reply
LisaShiroma238
LisaShiroma238 Feb. 18 at 1:47 PM
$TELA Medical device company with reimbursement risk.
0 · Reply
KylaGPS10x
KylaGPS10x Feb. 17 at 1:54 PM
$TELA revenue of 100 million should be trading at 2-3x sales this will go to $3 this year
0 · Reply
Latest News on TELA
TELA Bio to Announce Fourth Quarter and Full Year 2025 Financial Results

Mar 10, 2026, 4:05 PM EDT - 11 days ago

TELA Bio to Announce Fourth Quarter and Full Year 2025 Financial Results

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Feb 20, 2026, 4:05 PM EST - 4 weeks ago

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

TELA Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference

Nov 19, 2025, 8:30 AM EST - 4 months ago

TELA Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference

These Analysts Cut Their Forecasts On TELA Bio After Q3 Earnings

Nov 14, 2025, 11:42 AM EST - 4 months ago

These Analysts Cut Their Forecasts On TELA Bio After Q3 Earnings

TELA Bio Announces Pricing of $13.0 Million Underwritten Registered Direct Offering of Common Stock and Pre-Funded Warrants

Nov 13, 2025, 4:21 PM EST - 4 months ago

TELA Bio Announces Pricing of $13.0 Million Underwritten Registered Direct Offering of Common Stock and Pre-Funded Warrants

TELA Bio Reports Third Quarter 2025 Financial Results and Refinancing and Upsizing of Credit Facility

Nov 13, 2025, 4:01 PM EST - 4 months ago

TELA Bio Reports Third Quarter 2025 Financial Results and Refinancing and Upsizing of Credit Facility

TELA Bio Announces Addition of Betty Jo Rocchio to Board of Directors and the Departure of Director Lisa Colleran

Oct 9, 2025, 4:05 PM EDT - 5 months ago

TELA Bio Announces Addition of Betty Jo Rocchio to Board of Directors and the Departure of Director Lisa Colleran

TELA Bio Reports Second Quarter 2025 Financial Results

Aug 11, 2025, 4:03 PM EDT - 7 months ago

TELA Bio Reports Second Quarter 2025 Financial Results

TELA Bio to Participate in the Canaccord Genuity 45th Annual Growth Conference

Jul 23, 2025, 4:03 PM EDT - 8 months ago

TELA Bio to Participate in the Canaccord Genuity 45th Annual Growth Conference

TELA Bio to Announce Second Quarter 2025 Financial Results

Jul 21, 2025, 4:03 PM EDT - 8 months ago

TELA Bio to Announce Second Quarter 2025 Financial Results

TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Jun 6, 2025, 4:05 PM EDT - 10 months ago

TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

TELA Bio Announces European Commercial Launch of OviTex® Inguinal for Robotic and Laparoscopic Inguinal Hernia Repair

Jun 3, 2025, 4:05 PM EDT - 10 months ago

TELA Bio Announces European Commercial Launch of OviTex® Inguinal for Robotic and Laparoscopic Inguinal Hernia Repair

TELA Bio Appoints Jeffrey Blizard as President

Jun 2, 2025, 8:30 AM EDT - 10 months ago

TELA Bio Appoints Jeffrey Blizard as President

TELA Bio to Participate in the 2025 Jefferies Global Healthcare Conference

May 22, 2025, 4:05 PM EDT - 10 months ago

TELA Bio to Participate in the 2025 Jefferies Global Healthcare Conference

TELA Bio to Announce First Quarter 2025 Financial Results

Apr 17, 2025, 4:05 PM EDT - 1 year ago

TELA Bio to Announce First Quarter 2025 Financial Results

TELA Bio Reports Fourth Quarter and Full Year 2024 Financial Results

Mar 20, 2025, 4:05 PM EDT - 1 year ago

TELA Bio Reports Fourth Quarter and Full Year 2024 Financial Results

TELA Bio to Announce Fourth Quarter and Full Year 2024 Financial Results

Feb 27, 2025, 4:05 PM EST - 1 year ago

TELA Bio to Announce Fourth Quarter and Full Year 2024 Financial Results

TELA Bio to Participate in Piper Sandler's 36th Annual Healthcare Conference

Nov 19, 2024, 4:05 PM EST - 1 year ago

TELA Bio to Participate in Piper Sandler's 36th Annual Healthcare Conference

TELA Bio Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters' Option to Purchase Additional Shares

Oct 24, 2024, 4:05 PM EDT - 1 year ago

TELA Bio Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters' Option to Purchase Additional Shares

TELA Bio Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

Oct 23, 2024, 8:07 AM EDT - 1 year ago

TELA Bio Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

TELA Bio Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Oct 22, 2024, 4:05 PM EDT - 1 year ago

TELA Bio Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

TELA Bio to Announce Third Quarter 2024 Financial Results

Oct 17, 2024, 4:05 PM EDT - 1 year ago

TELA Bio to Announce Third Quarter 2024 Financial Results

TELA Bio Reports Second Quarter 2024 Financial Results and Reiterates Full Year 2024 Revenue Guidance

Aug 12, 2024, 4:05 PM EDT - 1 year ago

TELA Bio Reports Second Quarter 2024 Financial Results and Reiterates Full Year 2024 Revenue Guidance

TELA Bio to Announce Second Quarter 2024 Financial Results

Jul 22, 2024, 4:05 PM EDT - 1 year ago

TELA Bio to Announce Second Quarter 2024 Financial Results

TELA Bio Appoints Jeffrey Blizard to its Board of Directors

Jun 4, 2024, 4:05 PM EDT - 1 year ago

TELA Bio Appoints Jeffrey Blizard to its Board of Directors

TELA Bio Appoints Greg Firestone as Chief Commercial Officer

May 20, 2024, 4:03 PM EDT - 1 year ago

TELA Bio Appoints Greg Firestone as Chief Commercial Officer

TELA Bio Reports First Quarter 2024 Financial Results

May 9, 2024, 4:05 PM EDT - 2 years ago

TELA Bio Reports First Quarter 2024 Financial Results

TELA Bio to Announce First Quarter 2024 Financial Results

Apr 25, 2024, 7:00 AM EDT - 2 years ago

TELA Bio to Announce First Quarter 2024 Financial Results

TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex® IHR – Addressing the Need for a More Natural Repair in Inguinal Hernia Procedures

Apr 15, 2024, 7:00 AM EDT - 2 years ago

TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex® IHR – Addressing the Need for a More Natural Repair in Inguinal Hernia Procedures

TELA Bio Welcomes Acclaimed Surgeon as Vice President of Medical Affairs and Surgeon Strategy

Apr 8, 2024, 7:00 AM EDT - 2 years ago

TELA Bio Welcomes Acclaimed Surgeon as Vice President of Medical Affairs and Surgeon Strategy

TELA Bio Achieves Record Fourth Quarter and Full Year 2023 Revenues and Reports Complete Financial Results

Mar 21, 2024, 4:05 PM EDT - 2 years ago

TELA Bio Achieves Record Fourth Quarter and Full Year 2023 Revenues and Reports Complete Financial Results

TELA Bio Announces U.S. Commercial Launch of LIQUIFIX™ – the Only FDA-Approved Liquid Adhesive for Internal Use in Hernia Surgery

Mar 21, 2024, 7:00 AM EDT - 2 years ago

TELA Bio Announces U.S. Commercial Launch of LIQUIFIX™ – the Only FDA-Approved Liquid Adhesive for Internal Use in Hernia Surgery

TELA Bio Announces Sale of Distribution Rights for Wound Care Product to MIMEDX

Mar 20, 2024, 7:00 AM EDT - 2 years ago

TELA Bio Announces Sale of Distribution Rights for Wound Care Product to MIMEDX

TELA Bio to Announce Fourth Quarter and Full Year 2023 Financial Results

Feb 29, 2024, 7:00 AM EST - 2 years ago

TELA Bio to Announce Fourth Quarter and Full Year 2023 Financial Results

TELA Bio to Take Part in Connecting the Dots

Dec 5, 2023, 7:00 AM EST - 2 years ago

TELA Bio to Take Part in Connecting the Dots

TELA Bio to Participate in Piper Sandler's 35th Annual Healthcare Conference

Nov 16, 2023, 7:00 AM EST - 2 years ago

TELA Bio to Participate in Piper Sandler's 35th Annual Healthcare Conference

TELA Bio Reports Third Quarter 2023 Financial Results

Nov 9, 2023, 4:05 PM EST - 2 years ago

TELA Bio Reports Third Quarter 2023 Financial Results

TELA Bio to Announce Third Quarter 2023 Financial Results

Oct 26, 2023, 7:00 AM EDT - 2 years ago

TELA Bio to Announce Third Quarter 2023 Financial Results

TELA Bio to Participate in the Gilmartin Group Emerging Growth Company Showcase

Sep 18, 2023, 4:05 PM EDT - 2 years ago

TELA Bio to Participate in the Gilmartin Group Emerging Growth Company Showcase

TELA Bio Announces U.S. Commercial Launch of OviTex® PRS Long-Term Resorbable for Plastic and Reconstructive Surgery

Aug 16, 2023, 7:00 AM EDT - 2 years ago

TELA Bio Announces U.S. Commercial Launch of OviTex® PRS Long-Term Resorbable for Plastic and Reconstructive Surgery

TELA Bio Reports Second Quarter 2023 Financial Results

Aug 9, 2023, 4:03 PM EDT - 2 years ago

TELA Bio Reports Second Quarter 2023 Financial Results

TELA Bio to Announce Second Quarter 2023 Financial Results and Confirms Participation in the Canaccord Genuity 43rd Annual Growth Conference

Jul 26, 2023, 7:00 AM EDT - 2 years ago

TELA Bio to Announce Second Quarter 2023 Financial Results and Confirms Participation in the Canaccord Genuity 43rd Annual Growth Conference

New Survey Finds Strong Consumer Preference for More Natural Hernia Repair Options

Jun 15, 2023, 7:00 AM EDT - 3 years ago

New Survey Finds Strong Consumer Preference for More Natural Hernia Repair Options

TELA Bio to Participate in the Jefferies Global Healthcare Conference

May 25, 2023, 7:00 AM EDT - 3 years ago

TELA Bio to Participate in the Jefferies Global Healthcare Conference

TELA Bio Invests in Surgeon Training and Education with Upcoming Cadaver Lab

May 19, 2023, 7:00 AM EDT - 3 years ago

TELA Bio Invests in Surgeon Training and Education with Upcoming Cadaver Lab

TELA Bio Reports First Quarter 2023 Financial Results

May 11, 2023, 4:02 PM EDT - 3 years ago

TELA Bio Reports First Quarter 2023 Financial Results

TELA Bio Supports Diversity and Inclusion at International Hernia Collaboration Conference

May 9, 2023, 7:00 AM EDT - 3 years ago

TELA Bio Supports Diversity and Inclusion at International Hernia Collaboration Conference

TELA Bio to Participate in the JMP Securities Life Sciences Conference

May 2, 2023, 7:00 AM EDT - 3 years ago

TELA Bio to Participate in the JMP Securities Life Sciences Conference

TELA Bio to Announce First Quarter 2023 Financial Results

Apr 27, 2023, 7:00 AM EDT - 3 years ago

TELA Bio to Announce First Quarter 2023 Financial Results

Why TELA Bio Stock Is Dropping Today - TELA Bio (NASDAQ:TELA)

Apr 19, 2023, 2:27 PM EDT - 3 years ago

Why TELA Bio Stock Is Dropping Today - TELA Bio (NASDAQ:TELA)

Dr_Monkeybreath
Dr_Monkeybreath Mar. 18 at 5:11 PM
$TELA make that 3,333 @ .7335.👍
0 · Reply
Dr_Monkeybreath
Dr_Monkeybreath Mar. 18 at 4:07 PM
$TELA 1,800 @ .747.🔒
0 · Reply
KylaGPS10x
KylaGPS10x Mar. 4 at 2:22 PM
$TELA over 70 percent institutional owned any hint of turn around with the new sales force and this rockets towards $3-$5
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Mar. 4 at 2:38 AM
$TELA RSI: 51.29, MACD: -0.0338 Vol: 0.04, MA20: 0.81, MA50: 0.96 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Bears2354
Bears2354 Mar. 2 at 3:46 PM
$TELA
0 · Reply
KylaGPS10x
KylaGPS10x Feb. 24 at 6:11 PM
$TELA company is a screaming buy u der a dollar. Once the new sales team gets to work the sales will increase 2-3 fold
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 23 at 12:10 PM
$TELA Current Stock Price: $0.72 Contracts to trade: $2.5 TELA Mar 20 2026 Call Entry: $0.05 Exit: $0.06 ROI: 31% Hold ~30 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Bears2354
Bears2354 Feb. 19 at 9:17 PM
$TELA nice bullish 1 month pendent. Should take off soon. And he out of this sub $1
0 · Reply
LisaShiroma238
LisaShiroma238 Feb. 18 at 1:47 PM
$TELA Medical device company with reimbursement risk.
0 · Reply
KylaGPS10x
KylaGPS10x Feb. 17 at 1:54 PM
$TELA revenue of 100 million should be trading at 2-3x sales this will go to $3 this year
0 · Reply
RiskAdjustedAlpha
RiskAdjustedAlpha Feb. 17 at 12:44 PM
$TELA Pre-revenue biotech; early-stage.
0 · Reply
optionravi
optionravi Feb. 17 at 8:31 AM
$TELA Pre-revenue biotech; early-stage
0 · Reply
octavia8
octavia8 Feb. 9 at 3:20 PM
$TELA nice
0 · Reply
octavia8
octavia8 Feb. 9 at 2:56 PM
$TELA can we move
0 · Reply
ShadowFibonacci
ShadowFibonacci Feb. 9 at 2:38 PM
$TELA Oncology biotech; pipeline success is binary and high-risk.
0 · Reply
Bears2354
Bears2354 Feb. 6 at 5:45 PM
$TELA let's see a huge green candle on this one. It's been on a downtrend for some time! Let's go
0 · Reply
octavia8
octavia8 Feb. 6 at 4:37 PM
$TELA watching for another spike
0 · Reply
octavia8
octavia8 Feb. 5 at 9:21 PM
$TELA will this hit the same high tomorrow
0 · Reply
Bears2354
Bears2354 Feb. 5 at 8:10 PM
$TELA dammit man we were green. Buying oprotunity for sure
0 · Reply
xxxxxxx01
xxxxxxx01 Feb. 5 at 8:07 PM
$TELA is this company a scam or something ?? Wtf is this stock price
1 · Reply
LFC4EVER
LFC4EVER Feb. 5 at 7:59 PM
$TELA Why & WTF?
0 · Reply
octavia8
octavia8 Feb. 5 at 6:12 PM
$TELA is this dead?
0 · Reply